Janet Diane Douglas

age ~65

from Sonoma, CA

Get Report

Also known as:

Janet D Douglas
Janet F Bobinecz
Janet D Felt
Janet D Fect
Janette F Bobinecz
Janet Z
Missjanet Felt
Jane Felt
Michael Bobinecz

Connected to:

Janet Douglas Phones & Addresses

Sonoma, CA
Moraga, CA
Adamstown, MD
Yountville, CA
San Ramon, CA
Piedmont, CA
Granite Bay, CA
Southlake, TX
Swanton, MD
Danville, CA
Frederick, MD
Pleasanton, CA
San Francisco, CA

Isbn (Books And Publications)

India's Democracy

view source

Author
Janet Douglas

ISBN #
0297994050

India's Democracy

view source

Author
Janet Douglas

ISBN #
0297994069

India's Democracy

view source

Author
Janet Douglas

ISBN #
0393054691

India's Democracy

view source

Author
Janet Douglas

ISBN #
0393099083

Managing Workers' Compensation: A Human Resources Guide to Controlling Costs

view source

Author
Janet Douglas

ISBN #
0471596833

The Safe Approach: Controlling Risk for Workers in the Helping Professions

view source

Author
Janet Douglas

ISBN #
1930461038

Managing Workers' Compensation : A Human Resources Guide to Controlling Costs

view source

Author
Janet R. Douglas

ISBN #
0471117242

Managing Workers Compensation - A Human Resources Guide to Controlling Costs: 1996 Cumulative Supplement

view source

Author
Janet R. Douglas

ISBN #
0471166758

License Records

Janet R Douglas

License #:

464 - Expired

Category:

Veterinarian Medicine

Issued Date:

Feb 16, 1963

Renew Date:

Jan 1, 1998

Expiration Date:

Dec 31, 1998

Type:

Physical Therapist

Name / Title

Company / Classification

Phones & Addresses

Janet Douglas
Secretary

HERCULES TIRE & RUBBER SALES COMPANY OF MISSISSIPPI, INC

Janet Labranche Douglas
President

SHSF INCORPORATED

41 Sutter St, San Francisco, CA 94104

Us Patents

Lentiviral Packaging Constructs
view source
US Patent:

7070993, Jul 4, 2006
Filed:

Mar 13, 2002
Appl. No.:

10/097002
Inventors:

Michael Kaleko - Potomac MD, US
Tianci Luo - Clarksville MD, US
Ivan Plavec - Sunnyvale CA, US
Janet Lynn Douglas - San Francisco CA, US
Assignee:

Novartis AG - Basel
International Classification:

C12N 15/49
C12N 15/63
C12N 15/867
C12N 5/10
US Classification:

435325, 435366, 4353201
Abstract:

The present invention provides novel lentiviral packaging constructs that are useful for the establishment of stable packaging cell lines and producer cell lines. In particular, the present invention provides novel packaging cell lines that are capable of constitutively expressing high levels of lentiviral proteins.

Lentiviral Packaging Constructs
view source
US Patent:

7442551, Oct 28, 2008
Filed:

Jun 30, 2006
Appl. No.:

11/428118
Inventors:

Michael Kaleko - Potomac MD, US
Tianci Luo - Clarksville MD, US
Ivan Plavec - Sunnyvale CA, US
Janet Lynn Douglas - San Francisco CA, US
Assignee:

Novartis AG - Basel
International Classification:

C12N 15/63
C12N 15/64
C12N 15/867
C12N 5/10
A61K 48/00
C07H 21/02
C07H 21/04
US Classification:

435455, 435 691, 435325, 4353201
Abstract:

The present invention provides novel lentiviral packaging constructs that are useful for the establishment of stable packaging cell lines and producer cell lines. In particular, the present invention provides novel packaging cell lines that are capable of constitutively expressing high levels of lentiviral proteins.

Lentiviral Packaging Constructs
view source
US Patent:

7700342, Apr 20, 2010
Filed:

Jun 30, 2006
Appl. No.:

11/428092
Inventors:

Michael Kaleko - Potomac MD, US
Tianci Luo - Clarksville MD, US
Ivan Plavec - Sunnyvale CA, US
Janet Lynn Douglas - San Francisco CA, US
Assignee:

Novartis AG - Basel
International Classification:

C12N 15/49
US Classification:

4352351, 435212
Abstract:

The present invention provides novel lentiviral packaging constructs that are useful for the establishment of stable packaging cell lines and producer cell lines. In particular, the present invention provides novel packaging cell lines that are capable of constitutively expressing high levels of lentiviral proteins.

Lentiviral Packaging Constructs
view source
US Patent:

8183356, May 22, 2012
Filed:

Feb 5, 2007
Appl. No.:

11/671212
Inventors:

Michael Kaleko - Potomac MD, US
Tianci Luo - Clarksville MD, US
Ivan Plavec - Sunnyvale CA, US
Janet Lynn Douglas - San Francisco CA, US
Assignee:

Novartis AG - Basel
International Classification:

C07H 21/04
C12N 15/85
C12N 15/63
US Classification:

536 232, 435325, 4353201
Abstract:

The present invention provides novel lentiviral packaging constructs that are useful for the establishment of stable packaging cell lines and producer cell lines. In particular, the present invention provides novel packaging cell lines that are capable of constitutively expressing high levels of lentiviral proteins.

Methods Of Inhibition Of Mmtv-Like Viruses
view source
US Patent:

20050239753, Oct 27, 2005
Filed:

Jan 21, 2005
Appl. No.:

11/040929
Inventors:

Tomas Cihlar - Foster City CA, US
Janet Douglas - Portland OR, US
Craig Gibbs - Palo Alto CA, US
International Classification:

A61K031/675
US Classification:

514081000
Abstract:

The active metabolites of adefovir and tenofovir (PMEApp and PMPApp) are active against the MMTV RT. They are 25-fold more potent than 3TCppp, suggesting that tenofovir and adefovir may be effective at inhibiting the MMTV-like retroviruses, which may be the etiological agents involved in PBC and breast cancer.

Use Of Adefovir Or Tenofovir For Inhibiting Mmtv-Like Viruses Involved In Breast Cancer And Primary Biliary Cirrhosis
view source
US Patent:

20070281911, Dec 6, 2007
Filed:

Jan 21, 2005
Appl. No.:

10/586627
Inventors:

Tomas Cihlar - Foster City CA, US
Janet Douglas - Portland OR, US
Craig Gibbs - Palo Alto CA, US
Assignee:

GILEAD SCIENCES INC. - FORSTER CITY, CALIFORNIA CA
International Classification:

A61K 31/66
A61P 1/16
A61P 35/00
C12N 7/06
C12N 9/99
US Classification:

514114000, 435184000, 435238000
Abstract:

The active metabolites of adefovir and tenofovir (PMEApp and PMPApp) are active against the MMTV RT. They are 25-fold more potent than 3TCppp, suggesting that tenofovir and adefovir may be effective at inhibiting the MMTV-like retroviruses, which may be the etiological agents involved in PBC and breast cancer.